Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 461 entries
Sorted by: Best Match Show Resources per page
Resection of esophageal diverticulum through uniportal video-assisted thoracoscopic surgery.

Annals of translational medicine

Fiorelli A, Izzo AC, Arrigo E, Sgalambro F, Lepore MA, Cajozzo M, Castorina S, Lo Monte AI, Santini M, Caronia FP.
PMID: 29951501
Ann Transl Med. 2018 May;6(10):179. doi: 10.21037/atm.2018.04.12.

Open surgery remains the standard strategy for management of esophageal diverticulum in symptomatic patients. However, in the last years an increasing number of minimally invasive approaches have been proposed for this issue in order to reduce the surgical trauma...

Cite
Fiorelli A, Izzo AC, Arrigo E, et al. Resection of esophageal diverticulum through uniportal video-assisted thoracoscopic surgery. Ann Transl Med. 2018;6(10):179doi: 10.21037/atm.2018.04.12.
Fiorelli, A., Izzo, A. C., Arrigo, E., Sgalambro, F., Lepore, M. A., Cajozzo, M., Castorina, S., Lo Monte, A. I., Santini, M., & Caronia, F. P. (2018). Resection of esophageal diverticulum through uniportal video-assisted thoracoscopic surgery. Annals of translational medicine, 6(10), 179. https://doi.org/10.21037/atm.2018.04.12
Fiorelli, Alfonso, et al. "Resection of esophageal diverticulum through uniportal video-assisted thoracoscopic surgery." Annals of translational medicine vol. 6,10 (2018): 179. doi: https://doi.org/10.21037/atm.2018.04.12
Fiorelli A, Izzo AC, Arrigo E, Sgalambro F, Lepore MA, Cajozzo M, Castorina S, Lo Monte AI, Santini M, Caronia FP. Resection of esophageal diverticulum through uniportal video-assisted thoracoscopic surgery. Ann Transl Med. 2018 May;6(10):179. doi: 10.21037/atm.2018.04.12. PMID: 29951501; PMCID: PMC5994522.
Copy Download .nbib Format: NLM
Abscisic Acid Is a Major Regulator of Grape Berry Ripening Onset: New Insights into ABA Signaling Network.

Frontiers in plant science

Pilati S, Bagagli G, Sonego P, Moretto M, Brazzale D, Castorina G, Simoni L, Tonelli C, Guella G, Engelen K, Galbiati M, Moser C.
PMID: 28680438
Front Plant Sci. 2017 Jun 21;8:1093. doi: 10.3389/fpls.2017.01093. eCollection 2017.

Grapevine is a world-wide cultivated economically relevant crop. The process of berry ripening is non-climacteric and does not rely on the sole ethylene signal. Abscisic acid (ABA) is recognized as an important hormone of ripening inception and color development...

Cite
Pilati S, Bagagli G, Sonego P, et al. Abscisic Acid Is a Major Regulator of Grape Berry Ripening Onset: New Insights into ABA Signaling Network. Front Plant Sci. 2017;8:1093doi: 10.3389/fpls.2017.01093.
Pilati, S., Bagagli, G., Sonego, P., Moretto, M., Brazzale, D., Castorina, G., Simoni, L., Tonelli, C., Guella, G., Engelen, K., Galbiati, M., & Moser, C. (2017). Abscisic Acid Is a Major Regulator of Grape Berry Ripening Onset: New Insights into ABA Signaling Network. Frontiers in plant science, 81093. https://doi.org/10.3389/fpls.2017.01093
Pilati, Stefania, et al. "Abscisic Acid Is a Major Regulator of Grape Berry Ripening Onset: New Insights into ABA Signaling Network." Frontiers in plant science vol. 8 (2017): 1093. doi: https://doi.org/10.3389/fpls.2017.01093
Pilati S, Bagagli G, Sonego P, Moretto M, Brazzale D, Castorina G, Simoni L, Tonelli C, Guella G, Engelen K, Galbiati M, Moser C. Abscisic Acid Is a Major Regulator of Grape Berry Ripening Onset: New Insights into ABA Signaling Network. Front Plant Sci. 2017 Jun 21;8:1093. doi: 10.3389/fpls.2017.01093. eCollection 2017. PMID: 28680438; PMCID: PMC5479058.
Copy Download .nbib Format: NLM
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.

Oncotarget

Moretti F, D'Antona P, Finardi E, Barbetta M, Dominioni L, Poli A, Gini E, Noonan DM, Imperatori A, Rotolo N, Cattoni M, Campomenosi P.
PMID: 29212284
Oncotarget. 2017 Oct 11;8(55):94980-94996. doi: 10.18632/oncotarget.21739. eCollection 2017 Nov 07.

Selected circulating microRNAs (miRNAs) have been suggested for non-invasive screening of non-small cell lung cancer (NSCLC), however the numerous proposed miRNA signatures are inconsistent. Aiming to identify miRNAs suitable specifically for stage I-II NSCLC screening in serum/plasma samples, we...

Cite
Moretti F, D'Antona P, Finardi E, et al. Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer. Oncotarget. 2017;8(55):94980-94996doi: 10.18632/oncotarget.21739.
Moretti, F., D'Antona, P., Finardi, E., Barbetta, M., Dominioni, L., Poli, A., Gini, E., Noonan, D. M., Imperatori, A., Rotolo, N., Cattoni, M., & Campomenosi, P. (2017). Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer. Oncotarget, 8(55), 94980-94996. https://doi.org/10.18632/oncotarget.21739
Moretti, Francesca, et al. "Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer." Oncotarget vol. 8,55 (2017): 94980-94996. doi: https://doi.org/10.18632/oncotarget.21739
Moretti F, D'Antona P, Finardi E, Barbetta M, Dominioni L, Poli A, Gini E, Noonan DM, Imperatori A, Rotolo N, Cattoni M, Campomenosi P. Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer. Oncotarget. 2017 Oct 11;8(55):94980-94996. doi: 10.18632/oncotarget.21739. eCollection 2017 Nov 07. PMID: 29212284; PMCID: PMC5706930.
Copy Download .nbib Format: NLM
Tackling dipeptidyl peptidase IV in neurological disorders.

Neural regeneration research

Al-Badri G, Leggio GM, Musumeci G, Marzagalli R, Drago F, Castorina A.
PMID: 29451201
Neural Regen Res. 2018 Jan;13(1):26-34. doi: 10.4103/1673-5374.224365.

Dipeptidyl peptidase IV (DPP-IV) is a serine protease best known for its role in inactivating glucagon-like peptide-1 (GLP-1), pituitary adenylate cyclase-activating polypeptide (PACAP) and glucose-dependent insulinotropic peptide (GIP), three stimulators of pancreatic insulin secretion with beneficial effects on glucose...

Cite
Al-Badri G, Leggio GM, Musumeci G, et al. Tackling dipeptidyl peptidase IV in neurological disorders. Neural Regen Res. 2018;13(1):26-34doi: 10.4103/1673-5374.224365.
Al-Badri, G., Leggio, G. M., Musumeci, G., Marzagalli, R., Drago, F., & Castorina, A. (2018). Tackling dipeptidyl peptidase IV in neurological disorders. Neural regeneration research, 13(1), 26-34. https://doi.org/10.4103/1673-5374.224365
Al-Badri, Ghaith, et al. "Tackling dipeptidyl peptidase IV in neurological disorders." Neural regeneration research vol. 13,1 (2018): 26-34. doi: https://doi.org/10.4103/1673-5374.224365
Al-Badri G, Leggio GM, Musumeci G, Marzagalli R, Drago F, Castorina A. Tackling dipeptidyl peptidase IV in neurological disorders. Neural Regen Res. 2018 Jan;13(1):26-34. doi: 10.4103/1673-5374.224365. PMID: 29451201; PMCID: PMC5840985.
Copy Download .nbib Format: NLM
FCoV Viral Sequences of Systemically Infected Healthy Cats Lack Gene Mutations Previously Linked to the Development of FIP.

Pathogens (Basel, Switzerland)

Lutz M, Steiner AR, Cattori V, Hofmann-Lehmann R, Lutz H, Kipar A, Meli ML.
PMID: 32722056
Pathogens. 2020 Jul 24;9(8). doi: 10.3390/pathogens9080603.

Feline infectious peritonitis (FIP)-the deadliest infectious disease of young cats in shelters or catteries-is induced by highly virulent feline coronaviruses (FCoVs) emerging in infected hosts after mutations of less virulent FCoVs. Previous studies have shown that some mutations in...

Cite
Lutz M, Steiner AR, Cattori V, et al. FCoV Viral Sequences of Systemically Infected Healthy Cats Lack Gene Mutations Previously Linked to the Development of FIP. Pathogens. 2020;9(8)doi: 10.3390/pathogens9080603.
Lutz, M., Steiner, A. R., Cattori, V., Hofmann-Lehmann, R., Lutz, H., Kipar, A., & Meli, M. L. (2020). FCoV Viral Sequences of Systemically Infected Healthy Cats Lack Gene Mutations Previously Linked to the Development of FIP. Pathogens (Basel, Switzerland), 9(8), . https://doi.org/10.3390/pathogens9080603
Lutz, Mirjam, et al. "FCoV Viral Sequences of Systemically Infected Healthy Cats Lack Gene Mutations Previously Linked to the Development of FIP." Pathogens (Basel, Switzerland) vol. 9,8 (2020). doi: https://doi.org/10.3390/pathogens9080603
Lutz M, Steiner AR, Cattori V, Hofmann-Lehmann R, Lutz H, Kipar A, Meli ML. FCoV Viral Sequences of Systemically Infected Healthy Cats Lack Gene Mutations Previously Linked to the Development of FIP. Pathogens. 2020 Jul 24;9(8). doi: 10.3390/pathogens9080603. PMID: 32722056; PMCID: PMC7459962.
Copy Download .nbib Format: NLM
Dopamine: an immune transmitter.

Neural regeneration research

Thomas Broome S, Louangaphay K, Keay KA, Leggio GM, Musumeci G, Castorina A.
PMID: 32594028
Neural Regen Res. 2020 Dec;15(12):2173-2185. doi: 10.4103/1673-5374.284976.

The dopaminergic system controls several vital central nervous system functions, including the control of movement, reward behaviors and cognition. Alterations of dopaminergic signaling are involved in the pathogenesis of neurodegenerative and psychiatric disorders, in particular Parkinson's disease, which are...

Cite
Thomas Broome S, Louangaphay K, Keay KA, et al. Dopamine: an immune transmitter. Neural Regen Res. 2020;15(12):2173-2185doi: 10.4103/1673-5374.284976.
Thomas Broome, S., Louangaphay, K., Keay, K. A., Leggio, G. M., Musumeci, G., & Castorina, A. (2020). Dopamine: an immune transmitter. Neural regeneration research, 15(12), 2173-2185. https://doi.org/10.4103/1673-5374.284976
Thomas Broome, Sarah, et al. "Dopamine: an immune transmitter." Neural regeneration research vol. 15,12 (2020): 2173-2185. doi: https://doi.org/10.4103/1673-5374.284976
Thomas Broome S, Louangaphay K, Keay KA, Leggio GM, Musumeci G, Castorina A. Dopamine: an immune transmitter. Neural Regen Res. 2020 Dec;15(12):2173-2185. doi: 10.4103/1673-5374.284976. PMID: 32594028; PMCID: PMC7749467.
Copy Download .nbib Format: NLM
ATG7 immunohistochemical expression in Malignant Pleural Mesothelioma. A preliminary report.

Histology and histopathology

Rapisarda V, Broggi G, Caltabiano R, Lombardo C, Castorina S, Trovato A, Ledda C, Filetti V, Loreto C.
PMID: 34761371
Histol Histopathol. 2021 Nov 11;18396. doi: 10.14670/HH-18-396. Epub 2021 Nov 11.

Literature evidence has demonstrated a high incidence of asbestos-related malignant pleural mesothelioma (MPM) in a Sicilian town (Biancavilla, Italy), where fluoro-edenite (FE) fibers were discovered some decades ago. As ATG7 immunohistochemical analysis has been ascribed as a prognostic tool...

Cite
Rapisarda V, Broggi G, Caltabiano R, et al. ATG7 immunohistochemical expression in Malignant Pleural Mesothelioma. A preliminary report. Histol Histopathol. 2021;18396doi: 10.14670/HH-18-396.
Rapisarda, V., Broggi, G., Caltabiano, R., Lombardo, C., Castorina, S., Trovato, A., Ledda, C., Filetti, V., & Loreto, C. (2021). ATG7 immunohistochemical expression in Malignant Pleural Mesothelioma. A preliminary report. Histology and histopathology, 18396. https://doi.org/10.14670/HH-18-396
Rapisarda, Venerando, et al. "ATG7 immunohistochemical expression in Malignant Pleural Mesothelioma. A preliminary report." Histology and histopathology vol. (2021): 18396. doi: https://doi.org/10.14670/HH-18-396
Rapisarda V, Broggi G, Caltabiano R, Lombardo C, Castorina S, Trovato A, Ledda C, Filetti V, Loreto C. ATG7 immunohistochemical expression in Malignant Pleural Mesothelioma. A preliminary report. Histol Histopathol. 2021 Nov 11;18396. doi: 10.14670/HH-18-396. Epub 2021 Nov 11. PMID: 34761371.
Copy Download .nbib Format: NLM
Therapeutic potential of TRPM8 antagonists in prostate cancer.

Scientific reports

Di Donato M, Ostacolo C, Giovannelli P, Di Sarno V, Monterrey IMG, Campiglia P, Migliaccio A, Bertamino A, Castoria G.
PMID: 34853378
Sci Rep. 2021 Dec 01;11(1):23232. doi: 10.1038/s41598-021-02675-4.

Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate cancer, although its mechanism of action remains unclear. Here, we have characterized and investigated the effects of TRPM8 modulators in prostate cancer aggressiveness disclosing the molecular mechanism underlying...

Cite
Di Donato M, Ostacolo C, Giovannelli P, et al. Therapeutic potential of TRPM8 antagonists in prostate cancer. Sci Rep. 2021;11(1):23232doi: 10.1038/s41598-021-02675-4.
Di Donato, M., Ostacolo, C., Giovannelli, P., Di Sarno, V., Monterrey, I. M. G., Campiglia, P., Migliaccio, A., Bertamino, A., & Castoria, G. (2021). Therapeutic potential of TRPM8 antagonists in prostate cancer. Scientific reports, 11(1), 23232. https://doi.org/10.1038/s41598-021-02675-4
Di Donato, Marzia, et al. "Therapeutic potential of TRPM8 antagonists in prostate cancer." Scientific reports vol. 11,1 (2021): 23232. doi: https://doi.org/10.1038/s41598-021-02675-4
Di Donato M, Ostacolo C, Giovannelli P, Di Sarno V, Monterrey IMG, Campiglia P, Migliaccio A, Bertamino A, Castoria G. Therapeutic potential of TRPM8 antagonists in prostate cancer. Sci Rep. 2021 Dec 01;11(1):23232. doi: 10.1038/s41598-021-02675-4. PMID: 34853378; PMCID: PMC8636514.
Copy Download .nbib Format: NLM
Exploiting the mechanism of estrogen-induced transcription to fight breast cancer.

Experimental & molecular medicine

Perillo B, Castoria G, Migliaccio A.
PMID: 34326470
Exp Mol Med. 2021 Jul;53(7):1205-1206. doi: 10.1038/s12276-021-00656-1. Epub 2021 Jul 29.

No abstract available.

Cite
Perillo B, Castoria G, Migliaccio A. Exploiting the mechanism of estrogen-induced transcription to fight breast cancer. Exp Mol Med. 2021;53(7):1205-1206doi: 10.1038/s12276-021-00656-1.
Perillo, B., Castoria, G., & Migliaccio, A. (2021). Exploiting the mechanism of estrogen-induced transcription to fight breast cancer. Experimental & molecular medicine, 53(7), 1205-1206. https://doi.org/10.1038/s12276-021-00656-1
Perillo, Bruno, et al. "Exploiting the mechanism of estrogen-induced transcription to fight breast cancer." Experimental & molecular medicine vol. 53,7 (2021): 1205-1206. doi: https://doi.org/10.1038/s12276-021-00656-1
Perillo B, Castoria G, Migliaccio A. Exploiting the mechanism of estrogen-induced transcription to fight breast cancer. Exp Mol Med. 2021 Jul;53(7):1205-1206. doi: 10.1038/s12276-021-00656-1. Epub 2021 Jul 29. PMID: 34326470; PMCID: PMC8333043.
Copy Download .nbib Format: NLM
Improving clinical interpretation of five KRIT1 and PDCD10 intronic variants.

Clinical genetics

Fusco C, Nardella G, Petracca A, Ronchi D, Paciello N, Di Giacomo M, Gambardella S, Lanfranconi S, Zampatti S, D'Agruma L, Micale L, Castori M.
PMID: 33604894
Clin Genet. 2021 Jun;99(6):829-835. doi: 10.1111/cge.13944. Epub 2021 Feb 25.

Cerebral cavernous malformation (CCM) is a vascular malformation of the central nervous system which may occur sporadically or segregate within families due to heterozygous variants in KRIT1/CCM1, MGC4607/CCM2 or PDCD10/CCM3. Intronic variants are not uncommon in familial CCM, but...

Cite
Fusco C, Nardella G, Petracca A, et al. Improving clinical interpretation of five KRIT1 and PDCD10 intronic variants. Clin Genet. 2021;99(6):829-835doi: 10.1111/cge.13944.
Fusco, C., Nardella, G., Petracca, A., Ronchi, D., Paciello, N., Di Giacomo, M., Gambardella, S., Lanfranconi, S., Zampatti, S., D'Agruma, L., Micale, L., & Castori, M. (2021). Improving clinical interpretation of five KRIT1 and PDCD10 intronic variants. Clinical genetics, 99(6), 829-835. https://doi.org/10.1111/cge.13944
Fusco, Carmela, et al. "Improving clinical interpretation of five KRIT1 and PDCD10 intronic variants." Clinical genetics vol. 99,6 (2021): 829-835. doi: https://doi.org/10.1111/cge.13944
Fusco C, Nardella G, Petracca A, Ronchi D, Paciello N, Di Giacomo M, Gambardella S, Lanfranconi S, Zampatti S, D'Agruma L, Micale L, Castori M. Improving clinical interpretation of five KRIT1 and PDCD10 intronic variants. Clin Genet. 2021 Jun;99(6):829-835. doi: 10.1111/cge.13944. Epub 2021 Feb 25. PMID: 33604894.
Copy Download .nbib Format: NLM
Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study).

BMJ open

Ornaghi S, Colciago E, Vaglio Tessitore I, Abbamondi A, Antolini L, Locatelli A, Inversetti A, Pintucci A, Cetin I, Bracco B, Fabbri E, Sala V, Meroni M, Volpe G, Benedetti S, Bulfoni C, Marconi A, Lagrasta F, Paolini CL, Mazza E, Candiani M, Valsecchi L, Smid M, Pasi F, Pozzoni M, Castoldi M, Vignali M, Dal Molin G, Guarano A, Pellegrino A, Callegari C, Betti M, Lazzarin S, Prefumo F, Zanardini C, Parolin V, Catalano A, Barbolini E, Antonazzo P, Pignatti L, Tintoni M, Spelzini F, Martinelli A, Facchinetti F, Chiossi G, Vergani P.
PMID: 34873004
BMJ Open. 2021 Dec 06;11(12):e052510. doi: 10.1136/bmjopen-2021-052510.

INTRODUCTION: The term placenta praevia defines a placenta that lies over the internal os, whereas the term low-lying placenta identifies a placenta that is partially implanted in the lower uterine segment with the inferior placental edge located at 1-20...

Cite
Ornaghi S, Colciago E, Vaglio Tessitore I, et al. Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study). BMJ Open. 2021;11(12):e052510doi: 10.1136/bmjopen-2021-052510.
Ornaghi, S., Colciago, E., Vaglio Tessitore, I., Abbamondi, A., Antolini, L., Locatelli, A., Inversetti, A., Pintucci, A., Cetin, I., Bracco, B., Fabbri, E., Sala, V., Meroni, M., Volpe, G., Benedetti, S., Bulfoni, C., Marconi, A., Lagrasta, F., Paolini, C. L., Mazza, E., Candiani, M., Valsecchi, L., Smid, M., Pasi, F., Pozzoni, M., Castoldi, M., Vignali, M., Dal Molin, G., Guarano, A., Pellegrino, A., Callegari, C., Betti, M., Lazzarin, S., Prefumo, F., Zanardini, C., Parolin, V., Catalano, A., Barbolini, E., Antonazzo, P., Pignatti, L., Tintoni, M., Spelzini, F., Martinelli, A., Facchinetti, F., Chiossi, G., & Vergani, P. (2021). Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study). BMJ open, 11(12), e052510. https://doi.org/10.1136/bmjopen-2021-052510
Ornaghi, Sara, et al. "Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study)." BMJ open vol. 11,12 (2021): e052510. doi: https://doi.org/10.1136/bmjopen-2021-052510
Ornaghi S, Colciago E, Vaglio Tessitore I, Abbamondi A, Antolini L, Locatelli A, Inversetti A, Pintucci A, Cetin I, Bracco B, Fabbri E, Sala V, Meroni M, Volpe G, Benedetti S, Bulfoni C, Marconi A, Lagrasta F, Paolini CL, Mazza E, Candiani M, Valsecchi L, Smid M, Pasi F, Pozzoni M, Castoldi M, Vignali M, Dal Molin G, Guarano A, Pellegrino A, Callegari C, Betti M, Lazzarin S, Prefumo F, Zanardini C, Parolin V, Catalano A, Barbolini E, Antonazzo P, Pignatti L, Tintoni M, Spelzini F, Martinelli A, Facchinetti F, Chiossi G, Vergani P. Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study). BMJ Open. 2021 Dec 06;11(12):e052510. doi: 10.1136/bmjopen-2021-052510. PMID: 34873004.
Copy Download .nbib Format: NLM
MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer.

Frontiers in molecular biosciences

Scarpa M, Ruffolo C, Kotsafti A, Canal F, Erroi F, Basato S, DallAgnese L, Fiorot A, Pozza A, Brun P, Bassi N, Dei Tos A, Castoro C, Castagliuolo I, Scarpa M.
PMID: 34026821
Front Mol Biosci. 2021 May 07;8:624873. doi: 10.3389/fmolb.2021.624873. eCollection 2021.

Patients with mismatch repair (MMR)-deficient colorectal cancer (CRC) have a more favorable prognosis than patients with tumors with intact MMR. In order to obtain further insights on the reasons for this different outcome, we investigated the interplay between MMR...

Cite
Scarpa M, Ruffolo C, Kotsafti A, et al. MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer. Front Mol Biosci. 2021;8:624873doi: 10.3389/fmolb.2021.624873.
Scarpa, M., Ruffolo, C., Kotsafti, A., Canal, F., Erroi, F., Basato, S., DallAgnese, L., Fiorot, A., Pozza, A., Brun, P., Bassi, N., Dei Tos, A., Castoro, C., Castagliuolo, I., & Scarpa, M. (2021). MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer. Frontiers in molecular biosciences, 8624873. https://doi.org/10.3389/fmolb.2021.624873
Scarpa, Melania, et al. "MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer." Frontiers in molecular biosciences vol. 8 (2021): 624873. doi: https://doi.org/10.3389/fmolb.2021.624873
Scarpa M, Ruffolo C, Kotsafti A, Canal F, Erroi F, Basato S, DallAgnese L, Fiorot A, Pozza A, Brun P, Bassi N, Dei Tos A, Castoro C, Castagliuolo I, Scarpa M. MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer. Front Mol Biosci. 2021 May 07;8:624873. doi: 10.3389/fmolb.2021.624873. eCollection 2021. PMID: 34026821; PMCID: PMC8139190.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 461 entries